The partnership between Novo Nordisk and Hims & Hers is a response to Novo’s US rival Eli Lilly, which is behind the drug Zepbound and is collaborating with company Ro on telesales of Zepbound.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/hims-hers-stock-soars-on-wegovy-deal-with-novo/